Dose escalation experience with Ac-225-PSMA-617 in PSMA targeting alpha-radiation therapy of patients with mCRPC

被引：0
|
作者：
Kratochwil, C. [1 ]
Bruchertseifer, F. [2 ]
Giesel, F. L. [1 ]
Apostolidis, C. [2 ]
Haberkorn, U. [1 ]
Morgenstern, A. [2 ]
机构：
[1] Univ Heidelberg Hosp, Heidelberg, Germany
[2] European Commiss, Joint Res Ctr, Inst Transuranium Elements, Karlsruhe, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP154
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [1] Ac-225-PSMA-617 for PSMA targeting alpha-radiation therapy of 28 patients with mCRPC
    Kratochwil, C.
    Bruchertseifer, F.
    Giesel, F. L.
    Apostolidis, C.
    Haberkorn, U.
    Morgenstern, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S137 - S137
  • [2] Re: 225Ac-PSMA-617 for PSMA-Targeting Alpha-radiation Therapy of Patients with Metastatic Castration-resistant Prostate Cancer
    Hadaschik, Boris
    EUROPEAN UROLOGY, 2016, 70 (06) : 1080 - 1081
  • [3] 225Ac-PSMA-617 Targeted Therapy in MCRPC
    Pappas, Virginia
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (10) : 26N - 26N
  • [4] PSMA-targeting alpha-Radiation therapy with 225Actinium-PSMA-617: Dosimetry, toxicity and duration of tumor-control
    Kratochwil, C.
    Bruchertseifer, F.
    Giesel, F. L.
    Apostolidis, C.
    Haberkorn, U.
    Morgenstern, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S163 - S163
  • [5] Optimizing the treatment regimen for targeted alpha therapy of mCRPC with 225Ac-PSMA-617
    Bruchertseifer, Frank
    Kratochwil, Clemens
    Rathke, Hendrik
    Haberkorn, Uwe
    Morgenstern, Alfred
    Giesel, Frederik
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [6] Optimizing the treatment regimen for targeted alpha therapy of mCRPC with 225Ac-PSMA-617
    Kratochwil, C.
    Rathke, H.
    Bruchertseifer, F.
    Giesel, F. L.
    Haberkorn, U.
    Morgenstern, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S54 - S54
  • [7] Ac-225-PSMA617-a single center experience of 40 patients receiving PSMA-targeted Alpha therapy
    Kratochwil, Clemens
    Giesel, Frederik
    Bruchertseifer, Frank
    Rius-Montraveta, Maria
    Apostolidis, Christos
    Haberkorn, Uwe
    Morgenstern, Alfred
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [8] Safety and efficacy of Ac-225-PSMA-617 in metastatic castration resistant prostate cancer (mCRPC) after failure of Lu-177-PSMA
    Tauber, R. L.
    Feuerecker, B.
    Knorr, K.
    Beheshti, A.
    Seidl, C.
    D'Alessandria, C.
    Bruchertseifer, F.
    Retz, M.
    Gschwend, J. E.
    Weber, W.
    Morgenstern, A.
    Eiber, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [9] 225Ac-PSMA-617 After 177LuPSMA in mCRPC
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (03) : 19N - 19N
  • [10] [225Ac]Ac-PSMA-617 augmented [177Lu]Lu-PSMA-617 RLT in challenging advanced mCRPC patients
    Rosar, F.
    Krause, J.
    Bartholomae, M.
    Maus, S.
    Stemler, T.
    Hierlmeier, I.
    Linxweiler, J.
    Ezziddin, S.
    Khreish, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S315 - S315
12345